These Were the 2 Worst-Performing Stocks in the Dow Jones Industrial Average in February 2025
Among the blue-chip-laden Dow Jones Industrial Average (DJINDICES: ^DJI), the two worst-performing stocks in the month of ...
This High-Yield Dividend Stock Has Been Rising as the Nasdaq Fell Into Correction Territory
Famed investor Warren Buffett has a shockingly simple goal. Buy good companies at reasonable prices and hold them so he, and ...
Mutual of America Capital Management LLC Sells 337 Shares of Amedisys, Inc. (NASDAQ:AMED)
Mutual of America Capital Management LLC decreased its position in shares of Amedisys, Inc. (NASDAQ:AMED – Free Report) by ...
Enhabit, Inc. (EHAB) Q4 2024 Earnings Call Transcript
Q4 2024 Results Conference Call March 6, 2025 10:00 AM ETCompany ParticipantsJobie Williams - Senior Vice President ...
1 Unstoppable Artificial Intelligence (AI) Stock That I'm Buying Like There's No Tomorrow
Famed investor Warren Buffett once said, "Be fearful when others are greedy and be greedy when others are fearful." I think ...
People left 'terrified' of deep sea after man takes camera to ocean floor at midnight
YouTuber Barny Dillarstone left viewers stunned after heading on a late-night adventure underwater in Bali to find weird and ...
Truist Financial Reaffirms Their Hold Rating on Amedisys (AMED)
Truist Financial analyst David S Macdonald maintained a Hold rating on Amedisys (AMED – Research Report) today and set a price target of ...
AMED Q4 Earnings and Revenues Miss, Margins Dip, Stock Rises
Amedisys, for the fourth quarter of 2024, delivers year-over-year top-line growth across three of its segments - Home Health, ...
Handelsbanken Fonder AB Increases Stake in Amedisys, Inc. (NASDAQ:AMED)
Handelsbanken Fonder AB boosted its position in shares of Amedisys, Inc. (NASDAQ:AMED – Free Report) by 25.6% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund ...
Home Health Care News14d
Amedisys Reports Home Health Care Growth Amid Shadow Of DOJ-UHG Lawsuit
Amedisys Inc. (Nasdaq: AMED) experienced growth in home health during the fourth quarter of 2024, despite incurring merger-related costs from its pending ...
Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT), Amedisys (AMED) and CSPC Pharmaceutical Group (OtherCHJTF)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Sarepta Therapeutics (SRPT – Research Report), Amedisys ...
Amedisys (AMED) Reports Q4 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Amedisys (AMED) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics ...